![James W. Stave](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James W. Stave
Corporate Officer/Principal bij CD Diagnostics, Inc.
Profiel
James W.
Stave is currently the Vice President-Research & Development at CD Diagnostics, Inc. He was previously the Chief Science Officer & VP-Research & Development at Standard Diversified, Inc. from 1991 to 2011.
He received his undergraduate degree from Michigan Technological University and his doctorate from the University of Maryland.
Actieve functies van James W. Stave
Bedrijven | Functie | Begin |
---|---|---|
CD Diagnostics, Inc.
![]() CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | Corporate Officer/Principal | 08-05-2014 |
Eerdere bekende functies van James W. Stave
Bedrijven | Functie | Einde |
---|---|---|
STANDARD DIVERSIFIED INC | Hoofd Techniek/Wetenschap/O&O | 01-12-2011 |
Opleiding van James W. Stave
University of Maryland | Doctorate Degree |
Michigan Technological University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Standard Diversified, Inc.
![]() Standard Diversified, Inc. TobaccoConsumer Non-Durables Standard Diversified, Inc. is a holding company, which owns and operates subsidiaries in a variety of industries, including other tobacco products, insurance, and outdoor advertising. It operates through the following segments: Smokeless Products, Smoking Products, and NewGen Products. The Smokeless Product segment manufactures and markets moist snuff and contracts for and markets chewing tobacco products. The Smoking Products segment imports and markets cigarette papers, tubes, and related products; imports and markets finished cigars, MYO cigar tobaccos, and cigar wraps; and processes, packages, and markets pipe tobaccos. The NewGen Products segment trades e-cigarettes, e-liquids, vaporizers, and other related products; and distributes a wide assortment of vaping products to non-traditional retail outlets via VaporBeast and Vapor Shark. The company was founded by Martha C. Reider, Anne Cavanaugh and Richard C. Birkmeyer in 1990 and is headquartered in New York, NY. | Consumer Non-Durables |
CD Diagnostics, Inc.
![]() CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | Health Technology |